Want to see WAT full AI Analyst Report?
WAT Stock Chart & Stats
$327.77
-$3.31(-0.88%)
At close: 4:00 PM EST
$327.77
-$3.31(-0.88%)
Day’s Range― - ―
52-Week Range$275.05 - $414.15
Previous CloseN/A
Volume75.18K
Average Volume (3M)965.05K
Market Cap
$36.96B
Enterprise Value$28.38B
Total Cash (Recent Filing)$462.00M
Total Debt (Recent Filing)$5.57B
Price to Earnings (P/E)48.0
Beta0.74
Next Earnings
Aug 04, 2026EPS Estimate
3.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.88
Shares Outstanding98,185,850
10 Day Avg. Volume755,779
30 Day Avg. Volume965,055
Financial Highlights & Ratios
PEG Ratio75.61
Price to Book (P/B)8.83
Price to Sales (P/S)7.14
P/FCF Ratio41.87
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue7.53
Enterprise Value/Gross Profit13.68
Enterprise Value/Ebitda30.70
Forecast
1Y Price Target
$399.56Price Target Upside21.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
EPS Forecast (FY)14.52
Revenue Forecast (FY)$6.44B
Bulls Say, Bears Say
Bulls Say
Revenue Re-accelerationA material re‑acceleration in top‑line (TTM +19.1%) indicates strengthening end‑market demand and successful commercial execution. Durable revenue momentum supports scaling of recurring consumables and services, underpinning revenue visibility and long‑term installed‑base monetization.
Installed Base / Recurring RevenueA large installed base with ~22k replacement opportunities and explicit service attachment plans points to durable, higher‑frequency revenue from consumables and services. Recurring spend from instrument lifecycles stabilizes cashflows and raises lifetime customer value over multi‑year horizons.
Product & Regulatory MomentumRecent product launches and regulatory clearances expand the addressable market and strengthen differentiation in diagnostics and bioseparations. Durable product/approval wins support sustainable instrument adoption, recurring consumables, and higher‑margin service attach over several quarters.
Bears Say
Margin CompressionA sharp drop in net margin from ~20% to ~12% materially reduces operating leverage and cash available for reinvestment. If margin normalization is slow, profitability weakness can persist through integration cycles, limiting ROE recovery and constraining strategic flexibility.
Weakened Cash GenerationA >50% decline in free cash flow and weaker cash conversion reduce financial flexibility to fund synergies, capex, and debt service. Persistent lower FCF weakens ability to self‑fund growth initiatives and increases reliance on external financing during multi‑quarter integration phases.
China / Export ConstraintsRegulatory and DRG export constraints in China have driven double‑digit declines across businesses. Structural market access issues and required local product adaptation can persist, reducing growth in a large addressable market and making recovery dependent on time‑consuming localization.
WAT FAQ
What was Waters Corp’s price range in the past 12 months?
Waters Corp lowest stock price was $275.05 and its highest was $414.15 in the past 12 months.
What is Waters Corp’s market cap?
Waters Corp’s market cap is $36.96B.
When is Waters Corp’s upcoming earnings report date?
Waters Corp’s upcoming earnings report date is Aug 04, 2026 which is in 22 days.
How were Waters Corp’s earnings last quarter?
Waters Corp released its earnings results on May 05, 2026. The company reported $2.7 earnings per share for the quarter, beating the consensus estimate of $2.307 by $0.393.
Is Waters Corp overvalued?
According to Wall Street analysts Waters Corp’s price is currently Undervalued.
Does Waters Corp pay dividends?
Waters Corp does not currently pay dividends.
What is Waters Corp’s EPS estimate?
Waters Corp’s EPS estimate is 3.01.
How many shares outstanding does Waters Corp have?
Waters Corp has 98,185,850 shares outstanding.
What happened to Waters Corp’s price movement after its last earnings report?
Waters Corp reported an EPS of $2.7 in its last earnings report, beating expectations of $2.307. Following the earnings report the stock price went up 13.538%.
Which hedge fund is a major shareholder of Waters Corp?
Currently, no hedge funds are holding shares in WAT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Waters Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$399.56 (21.90% Upside)
$399.56 (21.90% Upside)
Blogger Sentiment
Bullish
WAT Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 2.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 1.0%
Last 30 Days ▲ 1.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.55%
12-Months-Change
Fundamentals
Return on Equity
8.04%
Trailing 12-Months
Asset Growth
434.26%
Trailing 12-Months
Company Description
Waters Corp
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
WAT Company Deck
WAT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive picture: strong combined‑company Q1 results with double‑digit organic growth in legacy businesses, a meaningful EPS beat (+20%), margin outperformance, an above‑plan start for the acquired BD businesses, and raised full‑year guidance. Management also outlined concrete integration actions (180‑day plan), product/regulatory wins, and synergy targets with clear timelines. Offsetting risks include a $20M respiratory headwind, notable China DRG and export constraints that drove declines in parts of the acquired businesses, Q1 GAAP acquisition‑related charges and modest free cash flow impacted by transaction costs, and prudent conservatism baked into the back‑half guide. Overall the positives—beats, raised guidance, tangible synergy progress and product/regulatory milestones—materially outweigh the near‑term operational and geographic headwinds.View all WAT earnings summariesWAT Revenue Breakdown
34.81% Waters instrument systems
19.95% Chemistry consumables
34.13% Waters service
7.70% TA instrument systems
3.41% TA service

WAT Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$399.56
▲(21.90% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
0.10% Insiders
29.76% Mutual Funds
0.39% Other Institutional Investors
43.12% Public Companies and
Individual Investors










